TLR2 Signaling in Myeloproliferative Neoplasms: Pathophysiological Roles, Mutation-Dependent Heterogeneity, and the Differential Efficacy of Ruxolitinib. [PDF]
Pokhrel A, Hakobyan N, Wang JC.
europepmc +1 more source
Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms. [PDF]
Barbui T.
europepmc +1 more source
Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026. [PDF]
Abu-Zeinah G +18 more
europepmc +1 more source
JAK2<sup>V617F</sup>-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers. [PDF]
Rodriguez MJ +15 more
europepmc +1 more source
Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease. [PDF]
Yang X +6 more
europepmc +1 more source
Early Radiological Intervention in Budd-Chiari Syndrome: Clinical Outcomes From a Single-Center Study. [PDF]
Ermongkonchai T +3 more
europepmc +1 more source
Mathematical modeling of <i>JAK2V617F</i> clonal expansion in a general population cohort. [PDF]
Snyder J +11 more
europepmc +1 more source
Single-cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML. [PDF]
Grabek J +15 more
europepmc +1 more source
Ropeginterferon alfa-2b in Polycythemia Vera: A systematic review and meta-analysis. [PDF]
Bakht D +12 more
europepmc +1 more source
Inflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities. [PDF]
Kaikavoosnejad F +9 more
europepmc +1 more source

